<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01601639</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00030955</org_study_id>
    <nct_id>NCT01601639</nct_id>
  </id_info>
  <brief_title>Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial</brief_title>
  <official_title>Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators goal is to compare the standard argon plasma coagulation (APC) treatment
      with endoscopic band ligation (EBL) in patients with Gastric Antral Vascular Ectasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastric antral vascular ectasia (GAVE) is a vascular structural malformation in the stomach
      that can lead to active or chronic intermittent gastrointestinal bleeding or chronic
      iron-deficiency anemia.

      The current standard endoscopic treatment is with APC. There have been multiple reports and
      case series in the literature about successful treatment with EBL for GAVE, even in cases
      where APC was unsuccessful for treatment of GAVE. Our goal is to compare the standard APC
      treatment with EBL in patients with Gastric Antral Vascular Ectasia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New event of upper gastrointestinal bleeding</measure>
    <time_frame>one year</time_frame>
    <description>Number of new episodes of upper gastrointestinal bleeding characterized by melena, hematemesis or quick and significant drop in hemoglobin levels will be documented after the first session of therapy.The hemoglobin level will be recorded before the procedure and 4,8,and 12 weeks after the first endoscopic treatment for GAVE to document changes from baseline. Patients showing stabilization of hemoglobin levels (no significant drop or improvement in levels) without other signs of gastrointestinal bleeding will be considered as treatment success.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of sessions required for GAVE eradication</measure>
    <time_frame>one year</time_frame>
    <description>The total number of endoscopic sessions required for total disappearance of the gastric antral vascular ectasia (GAVE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>one year</time_frame>
    <description>The investigators will document the total endoscopy time required for each procedure to compare between the two devices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusion requirements</measure>
    <time_frame>one year</time_frame>
    <description>The number of blood transfusions will be documented for each patient before and after the endoscopic treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron studies</measure>
    <time_frame>one year</time_frame>
    <description>Iron levels changes in blood serum will be monitored throughout the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferritin</measure>
    <time_frame>one year</time_frame>
    <description>Changes in ferritin levels will be monitored during the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Gastric Antral Vascular Ectasia</condition>
  <arm_group>
    <arm_group_label>Argon Plasma Coagulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with GAVE and/or chronic anemia, active GI bleeding, blood transfusion requirements</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic Band Ligation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with GAVE and/or chronic anemia, active GI bleeding, blood transfusion requirements</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoscopic Band Ligation</intervention_name>
    <description>Endoscopic band ligation device: 6 Shooter Saeed Multi-Band Ligator (Cook Medical/Endoscopy)</description>
    <arm_group_label>Endoscopic Band Ligation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Argon plasma Coagulation (APC) for GAVE</intervention_name>
    <description>APC treatment for gastric antral vascular ectasia (GAVE) Argon plasma coagulation device: ERBE VIO 300D (Elektromedizin GmBH)</description>
    <arm_group_label>Argon Plasma Coagulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients with GAVE identified at endoscopic examination, patients may have
             active GI bleeding, chronic anemia or drop in hemoglobin levels.

        Exclusion Criteria:

          -  Patients with previous endoscopic treatment for GAVE within the last 3 months,
             patients with GAVE without chronic anemia or active bleeding, patients in whom another
             possible source of GI bleeding is found
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G2X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Zepeda-GÃ³mez S, Sultanian R, Teshima C, Sandha G, Van Zanten S, Montano-Loza AJ. Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation. Endoscopy. 2015 Jun;47(6):538-40. doi: 10.1055/s-0034-1391395. Epub 2015 Feb 4.</citation>
    <PMID>25650636</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2012</study_first_posted>
  <last_update_submitted>January 24, 2017</last_update_submitted>
  <last_update_submitted_qc>January 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alberta</investigator_affiliation>
    <investigator_full_name>Sergio Zepeda</investigator_full_name>
    <investigator_title>Assistant Professor, Division of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Gastric Antral Vascular Ectasia</keyword>
  <keyword>Argon plasma Coagulation</keyword>
  <keyword>Endoscopic Band Ligation</keyword>
  <keyword>GAVE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Gastric Antral Vascular Ectasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

